Clinical Trial Update: The Study is Enrolling Kids From 8 to 17 Years Old. The BreathSmart Device Attaches to the Inhaler to Measure Adherence. [NA]

View source ↗

Summary

A completed pediatric asthma trial evaluating a BreathSmart device that attaches to an inhaler to measure adherence in ages 8-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Connecticut Children's Medical Center | Conditions: Asthma | NA | Status: COMPLETED | Results posted: 2023-04-07